Bridget E. Bunner

Array ( [id] => 7662279 [patent_doc_number] => 20110311548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO TREAT ASTHMA AND OTHER ALLERGIC AND INFLAMMATORY CONDITIONS OF THE RESPIRATORY SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/163593 [patent_app_country] => US [patent_app_date] => 2011-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 50119 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20110311548.pdf [firstpage_image] =>[orig_patent_app_number] => 13163593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7776372 [patent_doc_number] => 20120039914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR USING MHC CLASS II INVARIANT CHAIN POLYPEPTIDES AS A RECEPTOR FOR MACROPHAGE MIGRATION INHIBITORY FACTOR' [patent_app_type] => utility [patent_app_number] => 13/160265 [patent_app_country] => US [patent_app_date] => 2011-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6951 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20120039914.pdf [firstpage_image] =>[orig_patent_app_number] => 13160265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7720806 [patent_doc_number] => 20120010141 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'METHOD FOR STIMULATING WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/155750 [patent_app_country] => US [patent_app_date] => 2011-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6332 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20120010141.pdf [firstpage_image] =>[orig_patent_app_number] => 13155750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265843 [patent_doc_number] => 20120165267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'Apo-2 LIGAND/TRAIL VARIANTS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/153710 [patent_app_country] => US [patent_app_date] => 2011-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 29467 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566952 [patent_doc_number] => 20110287015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'MG53 COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/152077 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 30496 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287015.pdf [firstpage_image] =>[orig_patent_app_number] => 13152077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7566941 [patent_doc_number] => 20110287004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-24 [patent_title] => 'MG53 COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/152096 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30500 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20110287004.pdf [firstpage_image] =>[orig_patent_app_number] => 13152096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8928452 [patent_doc_number] => 20130184212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-18 [patent_title] => 'FIBRONECTIN BASED SCAFFOLD PROTEINS HAVING IMPROVED STABILITY' [patent_app_type] => utility [patent_app_number] => 13/699458 [patent_app_country] => US [patent_app_date] => 2011-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28824 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090817 [patent_doc_number] => 20110218230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'NATRIURETIC PEPTIDE RELATED FRAGMENT IN CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 13/108564 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34094 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218230.pdf [firstpage_image] =>[orig_patent_app_number] => 13108564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10154638 [patent_doc_number] => 09186390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Methods and uses of TIE2 binding and/or activating agents' [patent_app_type] => utility [patent_app_number] => 13/643171 [patent_app_country] => US [patent_app_date] => 2011-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 69 [patent_no_of_words] => 23082 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13643171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8964066 [patent_doc_number] => 20130203668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'PHARMACEUTICAL COMPOSITION COMPRISING ANTIPLATELET AGENTS AND AN ERYTHROPOIESIS STIMULATING AGENT' [patent_app_type] => utility [patent_app_number] => 13/638968 [patent_app_country] => US [patent_app_date] => 2011-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5710 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13638968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487391 [patent_doc_number] => 20110251108 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'METHODS AND MATERIALS RELATING TO STEM CELL GROWTH FACTOR-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/080504 [patent_app_country] => US [patent_app_date] => 2011-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47741 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251108.pdf [firstpage_image] =>[orig_patent_app_number] => 13080504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719876 [patent_doc_number] => 20120009211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUADROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/077512 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18330 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009211.pdf [firstpage_image] =>[orig_patent_app_number] => 13077512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6065644 [patent_doc_number] => 20110202033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CARDIAC ISCHEMIC INJURY' [patent_app_type] => utility [patent_app_number] => 13/077449 [patent_app_country] => US [patent_app_date] => 2011-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 33988 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20110202033.pdf [firstpage_image] =>[orig_patent_app_number] => 13077449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560876 [patent_doc_number] => 20110274708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'SHORT-FORM HUMAN MD-2 AS A NEGATIVE REGULATOR OF TOLL-LIKE RECEPTOR 4 SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/051390 [patent_app_country] => US [patent_app_date] => 2011-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 18212 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274708.pdf [firstpage_image] =>[orig_patent_app_number] => 13051390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7697065 [patent_doc_number] => 20110229525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-22 [patent_title] => 'MODULATION OF CYTOKINE SIGNALING' [patent_app_type] => utility [patent_app_number] => 13/047495 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22935 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20110229525.pdf [firstpage_image] =>[orig_patent_app_number] => 13047495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371365 [patent_doc_number] => 20120220755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'ORGANIC CATION TRANSPORTER POLYPEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/047399 [patent_app_country] => US [patent_app_date] => 2011-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9057 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13047399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9059651 [patent_doc_number] => 08546086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-01 [patent_title] => 'Use of neuregulin-β as an indicator and/or target' [patent_app_type] => utility [patent_app_number] => 13/035352 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7369 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13035352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048469 [patent_doc_number] => 20110207679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/030201 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9098 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207679.pdf [firstpage_image] =>[orig_patent_app_number] => 13030201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090466 [patent_doc_number] => 20110218169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Pirfenidone/Toll-Like Receptor (TLR) Agonist Compounds and Methods of Treating Neutropenia' [patent_app_type] => utility [patent_app_number] => 13/024661 [patent_app_country] => US [patent_app_date] => 2011-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10347 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218169.pdf [firstpage_image] =>[orig_patent_app_number] => 13024661 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8611911 [patent_doc_number] => 20130017224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'Nucleic Acid Molecules Encoding Rantes, and Compositions Comprising and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 13/577387 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 22630 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13577387 [rel_patent_id] =>[rel_patent_doc_number] =>)